SPOTLIGHT -
Movement on the germ-warfare front. Eye on Washington
Contemporary Pediatrics week in review: CDC recommendation for RSV, FDA approved eye drops, and more
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
Food Insecurity and the Dangers of Infant Formula Dilution
Academic performance not compromised with additional extracurricular activities in elementary school students
Fitness benefits of additional after-school physical activity were observed for school children in China compared to choice of activity, while academic performance was not compromised according to a recently published study in JAMA Pediatrics.
Demystifying Infant Formula
FDA approves phentolamine ophthalmic solution 0.75% eye drops for pharmacologically-induced mydriasis
Results from the phase 3 MIRA-4 pediatric trial demonstrated a favorable safety and tolerability profile with no reported adverse events. Rupa Wong, MD, offers thoughts on the approval, and why it may not change day-to-day practice when it comes to the pediatric population.
Discussing the upcoming RSV season, new tools, and vaccine hesitancy
In collaboration with Contemporary Pediatrics, Contemporary OB/GYN, and Contagion, Tina Tan, MD, FAAP, FIDSA, FPIDS, discusses the benefits of having new tools to fight RSV in infants, potential vaccine hesitancy, and RSV trends currently being observed.
